Artificial Intelligence digital treatment for pediatric ADHD based on neurophysiological measures: efficacy study of Sincrolab tool based on neurophysiological and neuropsychological measures
Research studyAges 8–11Spain
The study in practice
Understand this study
Who could participate?
Listed age limits: 8 years to 11 years.
Listed locations
Spain
Compensation
Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarity
Things to check before joining
Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Sincrolab Ltd
Sponsor type
Other organization
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
Spain
Age range
From 8 Years to 11 Years
Official registry ID
ISRCTN71041318
Official title
Show the full official title
Artificial Intelligence digital treatment for pediatric ADHD based on neurophysiological measures: efficacy study of Sincrolab tool based on neurophysiological and neuropsychological measures
Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
Recruitment & locations
Not recruiting
Spain
A listed location does not confirm current availability.
FAQ
Questions about this study
Who is behind this study?
The study sponsor is Sincrolab Ltd.
Who can participate?
Listed age limits: 8 years to 11 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.